Schedule 13G ownership disclosure
ZYNERBA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 98986X109
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.5200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-19-001070
- Form type
- SC 13G
- Filer
- GENESIS CAPITAL ADVISORS LLC
- CIK
- CIK 1439253
- Filed
- Jan 29, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership